The promise of riboswitches as potential antibacterial drug targets

International Journal of Medical Microbiology

Volumn 304, Issue 1, 2014, Pages 79-92

  Lünse, Christina E ^a   Schüller, Anna ^a   Mayer, Günter ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Adenine; FMN; Glucosamin 6 phosphate; Guanine; Lysine; Metabolite; Riboswitch; Ribozyme; TPP

Indexed keywords

ANTIINFECTIVE AGENT; COBAMAMIDE; COCARBOXYLASE; CYCLIC DI GMP; CYCLIC GMP DERIVATIVE; FLAVINE MONONUCLEOTIDE; GLUCOSAMINE 6 PHOSPHATE; GLUCOSAMINE DERIVATIVE; GLUTAMINE; GLYCINE; LYSINE; PURINE; THIAMINE PYROPHOSPHATASE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; BACTERIAL GROWTH; DRUG TARGETING; GENE EXPRESSION; NONHUMAN; RIBOSWITCH; RNA STRUCTURE; SHORT SURVEY;

ADENINE; FMN; GLUCOSAMIN-6-PHOSPHATE; GUANINE; LYSINE; METABOLITE; RIBOSWITCH; RIBOZYME; TPP;

ANTI-BACTERIAL AGENTS; BACTERIA; GENE EXPRESSION REGULATION, BACTERIAL; RIBOSWITCH;

EID: 84892514964     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2013.09.002     Document Type: Short Survey

References (118)

1. Ames T.D., Breaker R.R. Bacterial aptamers that selectively bind glutamine. RNA Biology 2011, 8(1):82-89.
2. Ames T.D., Rodionov D.A., et al. A eubacterial riboswitch class that senses the coenzyme tetrahydrofolate. Chemistry & Biology 2010, 17(7):681-685.
3. Andre G., Even S., et al. S-box and T-box riboswitches and antisense RNA control a sulfur metabolic operon of Clostridium acetobutylicum. Nucleic Acids Research 2008, 36(18):5955-5969.
4. Ataide S.F., Wilson S.N., et al. Mechanisms of resistance to an amino acid antibiotic that targets translation. ACS Chemical Biology 2007, 2(12):819-827.
5. Baker J.L., Sudarsan N., et al. Widespread genetic switches and toxicity resistance proteins for fluoride. Science 2012, 335(6065):233-235.
6. Barrick J.E., Breaker R.R. The distributions, mechanisms, and structures of metabolite-binding riboswitches. Genome Biology 2007, 8(11):R239.
7. Barrick J.E., Corbino K.A., et al. New RNA motifs suggest an expanded scope for riboswitches in bacterial genetic control. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(17):6421-6426.
8. Batey R.T., Gilbert S.D., et al. Structure of a natural guanine-responsive riboswitch complexed with the metabolite hypoxanthine. Nature 2004, 432(7015):411-415.
9. Blount K., Puskarz I., et al. Development and application of a high-throughput assay for glmS riboswitch activators. RNA Biology 2006, 3(2):77-81.
10. Blount K.F., Breaker R.R. Riboswitches as antibacterial drug targets. Nature Biotechnology 2006, 24(12):1558-1564.
11. Blount K.F., Wang J.X., et al. Antibacterial lysine analogs that target lysine riboswitches. Nature Chemical Biology 2007, 3(1):44-49.
12. Breaker R.R. Complex riboswitches. Science 2008, 319(5871):1795-1797.
13. Breaker R.R. Prospects for riboswitch discovery and analysis. Molecular Cell 2011, 43(6):867-879.
14. Breaker R.R. Riboswitches and the RNA world. Cold Spring Harbor Perspectives in Biology 2012, 4(2):1-15.
15. Browning D.F., Busby S.J. The regulation of bacterial transcription initiation. Nature Reviews Microbiology 2004, 2(1):57-65.
16. Cheah M.T., Wachter A., et al. Control of alternative RNA splicing and gene expression by eukaryotic riboswitches. Nature 2007, 447(7143):497-500.
17. Chen A.G., Sudarsan N., et al. Mechanism for gene control by a natural allosteric group I ribozyme. RNA 2011, 17(11):1967-1972.
18. Chen L., Cressina E., et al. Probing riboswitch-ligand interactions using thiamine pyrophosphate analogues. Organic & Biomolecular Chemistry 2012, 10(30):5924-5931.
19. Chen L., Cressina E., et al. A fragment-based approach to identifying ligands for riboswitches. ACS Chemical Biology 2010, 5(4):355-358.
20. Cochrane J.C., Lipchock S.V., et al. Structural and chemical basis for glucosamine 6-phosphate binding and activation of the glmS ribozyme. Biochemistry 2009, 48(15):3239-3246.
21. Cochrane J.C., Lipchock S.V., et al. Structural investigation of the GlmS ribozyme bound to Its catalytic cofactor. Chemistry & Biology 2007, 14(1):97-105.
22. Collins J.A., Irnov I., et al. Mechanism of mRNA destabilization by the glmS ribozyme. Genes & Development 2007, 21(24):3356-3368.
23. Corbino K.A., Barrick J.E., et al. Evidence for a second class of S-adenosylmethionine riboswitches and other regulatory RNA motifs in alpha-proteobacteria. Genome Biology 2005, 6(8):R70.
24. Cressina E., Chen L., et al. Identification of novel ligands for thiamine pyrophosphate (TPP) riboswitches. Biochemical Society Transactions 2011, 39(2):652-657.
25. Cressina E., Chen L.H., et al. Fragment screening against the thiamine pyrophosphate riboswitch thiM. Chemical Science 2011, 2(1):157-165.
26. Croft M.T., Moulin M., et al. Thiamine biosynthesis in algae is regulated by riboswitches. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(52):20770-20775.
27. Dambach M.D., Winkler W.C. Expanding roles for metabolite-sensing regulatory RNAs. Current Opinion In Microbiology 2009, 12(2):161-169.
28. Di Girolamo M., Busiello V., et al. Aspartokinase III repression and lysine analogs utilization for protein synthesis. Physiological Chemistry and Physics and Medical NMR 1990, 22(4):241-245.
29. Donald R.G., Skwish S., et al. A Staphylococcus aureus fitness test platform for mechanism-based profiling of antibacterial compounds. Chemistry & Biology 2009, 16(8):826-836.
30. Edwards T.E., Ferre-D'Amare A.R. Crystal structures of the thi-box riboswitch bound to thiamine pyrophosphate analogs reveal adaptive RNA-small molecule recognition. Structure 2006, 14(9):1459-1468.
31. Fuchs R.T., Grundy F.J., et al. The S(MK) box is a new SAM-binding RNA for translational regulation of SAM synthetase. Nature Structural & Molecular Biology 2006, 13(3):226-233.
32. Furukawa K., Gu H., et al. Identification of ligand analogues that control c-di-GMP riboswitches. ACS Chemical Biology 2012, 7(8):1436-1443.
33. Garst A.D., Heroux A., et al. Crystal structure of the lysine riboswitch regulatory mRNA element. The Journal of Biological Chemistry 2008, 283(33):22347-22351.
34. Gilbert S.D., Love C.E., et al. Mutational analysis of the purine riboswitch aptamer domain. Biochemistry 2007, 46(46):13297-13309.
35. Gilbert S.D., Mediatore S.J., et al. Modified pyrimidines specifically bind the purine riboswitch. Journal of the American Chemical Society 2006, 128(44):14214-14215.
36. Gilbert S.D., Reyes F.E., et al. Adaptive ligand binding by the purine riboswitch in the recognition of guanine and adenine analogs. Structure 2009, 17(6):857-868.
37. Grill S., Busenbender S., et al. The bifunctional flavokinase/flavin adenine dinucleotide synthetase from Streptomyces davawensis produces inactive flavin cofactors and is not involved in resistance to the antibiotic roseoflavin. Journal of Bacteriology 2008, 190(5):1546-1553.
38. Grundy F.J., Henkin T.M. The S box regulon: a new global transcription termination control system for methionine and cysteine biosynthesis genes in gram-positive bacteria. Molecular Microbiology 1998, 30(4):737-749.
39. Hemberger S., Pedrolli D.B., et al. RibM from Streptomyces davawensis is a riboflavin/roseoflavin transporter and may be useful for the optimization of riboflavin production strains. BMC Biotechnology 2011, 11:119.
40. Hengge R. Principles of c-di-GMP signalling in bacteria. Nature Reviews Microbiology 2009, 7(4):263-273.
41. Hermann T., Westhof E. RNA as a drug target: chemical, modelling, and evolutionary tools. Current Opinion in Biotechnology 1998, 9(1):66-73.
42. Hirshfield I.N., Zamecnik P.C. Thiosine-resistant mutants of Escherichia coli K-12 with growth-medium-dependent lysl-tRNA synthetase activity, I. Isolation and physiological characterization. Biochimica et Biophysica Acta 1972, 259(3):330-343.
43. Jacob F., Monod J. Genetic regulatory mechanisms in the synthesis of proteins. Journal of Molecular Biology 1961, 3:318-356.
44. Jia X., Zhang J., et al. Riboswitch control of aminoglycoside antibiotic resistance. Cell 2013, 152(1/2):68-81.
45. Kazanov M.D., Vitreschak A.G., et al. Abundance and functional diversity of riboswitches in microbial communities. BMC Genomics 2007, 8:347.
46. Kim J.N., Blount K.F., et al. Design and antimicrobial action of purine analogues that bind Guanine riboswitches. ACS Chemical Biology 2009, 4(11):915-927.
47. Kim J.N., Roth A., et al. Guanine riboswitch variants from Mesoplasma florum selectively recognize 2'-deoxyguanosine. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(41):16092-16097.
48. Klein D.J., Ferre-D'Amare A.R. Structural basis of glmS ribozyme activation by glucosamine-6-phosphate. Science 2006, 313(5794):1752-1756.
49. Kubodera T., Yamashita N., et al. Pyrithiamine resistance gene (ptrA) of Aspergillus oryzae: cloning, characterization and application as a dominant selectable marker for transformation. Bioscience, Biotechnology, and Biochemistry 2000, 64(7):1416-1421.
50. Lee E.R., Baker J.L., et al. An allosteric self-splicing ribozyme triggered by a bacterial second messenger. Science 2010, 329(5993):845-848.
51. Lee E.R., Blount K.F., et al. Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression. RNA Biology 2009, 6(2):187-194.
52. Lim J., Grove B.C., et al. Characteristics of ligand recognition by a glmS self-cleaving ribozyme. Angewandte Chemie 2006, 45(40):6689-6693.
53. Lu C., Smith A.M., et al. Crystal structures of the SAM-III/S(MK) riboswitch reveal the SAM-dependent translation inhibition mechanism. Nature Structural & Molecular Biology 2008, 15(10):1076-1083.
54. Lünse C.E., Schmidt M.S., et al. Carba-sugars activate the glmS-riboswitch of Staphylococcus aureus. ACS Chemical Biology 2011, 6(7):675-678.
55. Mack M., Grill S. Riboflavin analogs and inhibitors of riboflavin biosynthesis. Applied Microbiology and Biotechnology 2006, 71(3):265-275.
56. Mack M., van Loon A.P., et al. Regulation of riboflavin biosynthesis in Bacillus subtilis is affected by the activity of the flavokinase/flavin adenine dinucleotide synthetase encoded by ribC. Journal of Bacteriology 1998, 180(4):950-955.
57. Mandal M., Breaker R.R. Adenine riboswitches and gene activation by disruption of a transcription terminator. Nature Structural & Molecular Biology 2004, 11(1):29-35.
58. Mandal M., Breaker R.R. Gene regulation by riboswitches. Nature Reviews Molecular Cell Biology 2004, 5(6):451-463.
59. Mandal M., Lee M., et al. A glycine-dependent riboswitch that uses cooperative binding to control gene expression. Science 2004, 306(5694):275-279.
60. Mansjo M., Johansson J. The riboflavin analog roseoflavin targets an FMN-riboswitch and blocks Listeria monocytogenes growth, but also stimulates virulence gene-expression and infection. RNA Biology 2011, 8(4):674-680.
61. Mayer G., Famulok M. High-throughput-compatible assay for glmS riboswitch metabolite dependence. Chembiochem: A European Journal of Chemical Biology 2006, 7(4):602-604.
62. McCarthy T.J., Plog M.A., et al. Ligand requirements for glmS ribozyme self-cleavage. Chemistry & Biology 2005, 12(11):1221-1226.
63. McCord T.J., Cook D.E., et al. The synthesis and biological activities of some aza analogs of amino acids, li. 4-Azalysine, an inhibitory analog of lysine. Archives of Biochemistry and Biophysics 1964, 105:349-351.
64. McCown P.J., Roth A., et al. An expanded collection and refined consensus model of glmS ribozymes. RNA 2011, 17(4):728-736.
65. Miranda-Rios J. The THI-box riboswitch, or how RNA binds thiamin pyrophosphate. Structure 2007, 15(3):259-265.
66. Mironov A.S., Gusarov I., et al. Sensing small molecules by nascent RNA: a mechanism to control transcription in bacteria. Cell 2002, 111(5):747-756.
67. Mulhbacher J., Brouillette E., et al. Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways. PLoS Pathogens 2010, 6(4):e1000865.
68. Nahvi A., Barrick J.E., et al. Coenzyme B12 riboswitches are widespread genetic control elements in prokaryotes. Nucleic Acids Research 2004, 32(1):143-150.
69. Nudler E., Mironov A.S. The riboswitch control of bacterial metabolism. Trends in Biochemical Sciences 2004, 29(1):11-17.
70. Ontiveros-Palacios N., Smith A.M., et al. Molecular basis of gene regulation by the THI-box riboswitch. Molecular Microbiology 2008, 67(4):793-803.
71. Ott E., Stolz J., et al. The RFN riboswitch of Bacillus subtilis is a target for the antibiotic roseoflavin produced by Streptomyces davawensis. RNA Biology 2009, 6(3):276-280.
72. Pedrolli D.B., Matern A., et al. A highly specialized flavin mononucleotide riboswitch responds differently to similar ligands and confers roseoflavin resistance to Streptomyces davawensis. Nucleic Acids Research 2012, 40(17):8662-8673.
73. Poiata E., Meyer M.M., et al. A variant riboswitch aptamer class for S-adenosylmethionine common in marine bacteria. RNA 2009, 15(11):2046-2056.
74. Ramesh A., Winkler W.C. Magnesium-sensing riboswitches in bacteria. RNA Biology 2010, 7(1):77-83.
75. Regulski E.E., Moy R.H., et al. A widespread riboswitch candidate that controls bacterial genes involved in molybdenum cofactor and tungsten cofactor metabolism. Molecular Microbiology 2008, 68(4):918-932.
76. + ions and phosphates in a fluoride riboswitch. Nature 2012, 486(7401):85-89.
77. Rieder U., Kreutz C., et al. Folding of a transcriptionally acting preQ1 riboswitch. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(24):10804-10809.
78. Rodionov D.A., Vitreschak A.G., et al. Comparative genomics of the methionine metabolism in Gram-positive bacteria: a variety of regulatory systems. Nucleic Acids Research 2004, 32(11):3340-3353.
79. Roth A., Winkler W.C., et al. A riboswitch selective for the queuosine precursor preQ1 contains an unusually small aptamer domain. Nature Structural & Molecular Biology 2007, 14(4):308-317.
80. Schroeder R., Waldsich C., et al. Modulation of RNA function by aminoglycoside antibiotics. The EMBO Journal 2000, 19(1):1-9.
81. Schwalbe H., Buck J., et al. Structures of RNA switches: insight into molecular recognition and tertiary structure. Angewandte Chemie 2007, 46(8):1212-1219.
82. Serganov A., Huang L., et al. Structural insights into amino acid binding and gene control by a lysine riboswitch. Nature 2008, 455(7217):1263-1267.
83. Serganov A., Huang L., et al. Coenzyme recognition and gene regulation by a flavin mononucleotide riboswitch. Nature 2009, 458(7235):233-237.
84. Serganov A., Nudler E. A decade of riboswitches. Cell 2013, 152(1/2):17-24.
85. Serganov A., Patel D.J. Molecular recognition and function of riboswitches. Current Opinion in Structural Biology 2012, 22(3):279-286.
86. Serganov A., Polonskaia A., et al. Structural basis for gene regulation by a thiamine pyrophosphate-sensing riboswitch. Nature 2006, 441(7097):1167-1171.
87. Serganov A., Yuan Y.R., et al. Structural basis for discriminative regulation of gene expression by adenine- and guanine-sensing mRNAs. Chemistry & Biology 2004, 11(12):1729-1741.
88. Shanahan C.A., Gaffney B.L., et al. Differential analogue binding by two classes of c-di-GMP riboswitches. Journal of the American Chemical Society 2011, 133(39):15578-15592.
89. Shanahan C.A., Strobel S.A. The bacterial second messenger c-di-GMP: probing interactions with protein and RNA binding partners using cyclic dinucleotide analogs. Organic & Biomolecular Chemistry 2012, 10(46):9113-9129.
90. Shiota T., Folk J.E., et al. Inhibition of lysine utilization in bacteria by S-(beta-aminoethyl) cysteine and its reversal by lysine peptides. Archives of Biochemistry and Biophysics 1958, 77(2):372-377.
91. Smith K.D., Lipchock S.V., et al. Structural basis of ligand binding by a c-di-GMP riboswitch. Nature Structural & Molecular Biology 2009, 16(12):1218-1223.
92. Smith K.D., Lipchock S.V., et al. Structural and biochemical characterization of linear dinucleotide analogues bound to the c-di-GMP-I aptamer. Biochemistry 2012, 51(1):425-432.
93. Ster C., Allard M., et al. Experimental treatment of Staphylococcus aureus bovine intramammary infection using a guanine riboswitch ligand analog. Journal of Dairy Science 2013, 96(2):1000-1008.
94. Sudarsan N., Barrick J.E., et al. Metabolite-binding RNA domains are present in the genes of eukaryotes. RNA 2003, 9(6):644-647.
95. Sudarsan N., Cohen-Chalamish S., et al. Thiamine pyrophosphate riboswitches are targets for the antimicrobial compound pyrithiamine. Chemistry & Biology 2005, 12(12):1325-1335.
96. Sudarsan N., Lee E.R., et al. Riboswitches in eubacteria sense the second messenger cyclic di-GMP. Science 2008, 321(5887):411-413.
97. Sudarsan N., Wickiser J.K., et al. An mRNA structure in bacteria that controls gene expression by binding lysine. Genes & Development 2003, 17(21):2688-2697.
98. Tamayo R., Pratt J.T., et al. Roles of cyclic diguanylate in the regulation of bacterial pathogenesis. Annual Review of Microbiology 2007, 61:131-148.
99. Thore S., Frick C., et al. Structural basis of thiamine pyrophosphate analogues binding to the eukaryotic riboswitch. Journal of the American Chemical Society 2008, 130(26):8116-8117.
100. Thore S., Leibundgut M., et al. Structure of the eukaryotic thiamine pyrophosphate riboswitch with its regulatory ligand. Science 2006, 312(5777):1208-1211.
101. Trausch J.J., Ceres P., et al. The structure of a tetrahydrofolate-sensing riboswitch reveals two ligand binding sites in a single aptamer. Structure 2011, 19(10):1413-1423.
102. Vitreschak A.G., Rodionov D.A., et al. Regulation of riboflavin biosynthesis and transport genes in bacteria by transcriptional and translational attenuation. Nucleic Acids Research 2002, 30(14):3141-3151.
103. Vogl C., Grill S., et al. Characterization of riboflavin (vitamin B2) transport proteins from Bacillus subtilis and Corynebacterium glutamicum. Journal of Bacteriology 2007, 189(20):7367-7375.
104. Wachter A., Tunc-Ozdemir M., et al. Riboswitch control of gene expression in plants by splicing and alternative 3' end processing of mRNAs. The Plant Cell 2007, 19(11):3437-3450.
105. Wang G.N., Lau P.S., et al. Synthesis and evaluation of glucosamine-6-phosphate analogues as activators of glmS riboswitch. Tetrahedron 2012, 68(46):9405-9412.
106. Wang J.X., Breaker R.R. Riboswitches that sense S-adenosylmethionine and S-adenosylhomocysteine. Biochemistry and Cell Biology=Biochimie et Biologie Cellulaire 2008, 86(2):157-168.
107. Wang J.X., Lee E.R., et al. Riboswitches that sense S-adenosylhomocysteine and activate genes involved in coenzyme recycling. Molecular Cell 2008, 29(6):691-702.
108. Watson P.Y., Fedor M.J. The glmS riboswitch integrates signals from activating and inhibitory metabolites in vivo. Nature Structural & Molecular Biology 2011, 18(3):359-363.
109. Watson P.Y., Fedor M.J. The ydaO motif is an ATP-sensing riboswitch in Bacillus subtilis. Nature Chemical Biology 2012, 8(12):963-965.
110. Weinberg Z., Regulski E.E., et al. The aptamer core of SAM-IV riboswitches mimics the ligand-binding site of SAM-I riboswitches. RNA 2008, 14(5):822-828.
111. Weinberg Z., Wang J.X., et al. Comparative genomics reveals 104 candidate structured RNAs from bacteria, archaea, and their metagenomes. Genome Biology 2010, 11(3):R31.
112. Welz R., Breaker R.R. Ligand binding and gene control characteristics of tandem riboswitches in Bacillus anthracis. RNA 2007, 13(4):573-582.
113. Winkler W., Nahvi A., et al. Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression. Nature 2002, 419(6910):952-956.
114. Winkler W.C. Riboswitches and the role of noncoding RNAs in bacterial metabolic control. Current Opinion in Chemical Biology 2005, 9(6):594-602.
115. Winkler W.C., Cohen-Chalamish S., et al. An mRNA structure that controls gene expression by binding FMN. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(25):15908-15913.
116. Winkler W.C., Nahvi A., et al. Control of gene expression by a natural metabolite-responsive ribozyme. Nature 2004, 428(6980):281-286.
117. Winkler W.C., Nahvi A., et al. An mRNA structure that controls gene expression by binding S-adenosylmethionine. Nature Structural Biology 2003, 10(9):701-707.
118. Woolley D.W., White A.G. Selective reversible inhibition of microbial growth with pyrithiamine. The Journal of Experimental Medicine 1943, 78(6):489-497.